Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)

被引:11
作者
Kontogiorgis, CA [1 ]
Hadjipavlou-Litina, D [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Pharm, Dept Pharmaceut Chem, Thessaloniki 54124, Greece
关键词
QSAR; NO donors; NOS inhibitors; electronic factors; steric factors; lipophilicity;
D O I
10.1002/med.10012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This article evaluates the quantitative structure-activity relationships (QSAR) of nitric oxide (NO) radical donors and nitric oxide synthases (NOS) inhibitors, using the C-QSAR program of Biobyte. Furoxans, triazines, amidoximes, tetrazoles, imidazoles and N-omega-2-nilro-arylamino acid analogues were included in this survey. In nine out of seventeen cases, the clog P plays a significant part in the QSAR of the NO radical donors and of the NOS inhibition, Many of the compounds must be interacting with a hydrophobic space in a non-specific way. In some cases molecular refractivity CMR/MR as well as sterimol parameters (B-1 and L) are important, Electronic effects, with the exception of the Hammett's constant sigma and the Swain-Lupton parameter F, are not found to govern the biological activity. Stereochemical and electronic features are also found to be important. Indicator variables were used after the best model was found to account for the usual structural features. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:385 / 418
页数:34
相关论文
共 94 条
  • [1] AHLNER J, 1991, PHARMACOL REV, V43, P351
  • [2] FORMATION OF NITRIC-OXIDE BY CYTOCHROME P450-CATALYZED OXIDATION OF AROMATIC AMIDOXIMES
    ANDRONIKLION, V
    BOUCHER, JL
    DELAFORGE, M
    HENRY, Y
    MANSUY, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (01) : 452 - 458
  • [3] NO+, NO(CENTER-DOT), AND NO- DONATION BY S-NITROSOTHIOLS - IMPLICATIONS FOR REGULATION OF PHYSIOLOGICAL FUNCTIONS BY S-NITROSYLATION AND ACCELERATION OF DISULFIDE FORMATION
    ARNELLE, DR
    STAMLER, JS
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 318 (02) : 279 - 285
  • [4] BORN J, 1994, EFMC S PAR SEPT
  • [5] CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE
    BREDT, DS
    HWANG, PM
    GLATT, CE
    LOWENSTEIN, C
    REED, RR
    SNYDER, SH
    [J]. NATURE, 1991, 351 (6329) : 714 - 718
  • [6] THE NEUROPROTECTIVE EFFECT OF A NITRIC-OXIDE INHIBITOR IN A RAT MODEL OF FOCAL CEREBRAL-ISCHEMIA
    BUISSON, A
    PLOTKINE, M
    BOULU, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (04) : 766 - 767
  • [7] Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole
    Chabin, RM
    McCauley, E
    Calaycay, JR
    Kelly, TM
    MacNaul, KL
    Wolfe, GC
    Hutchinson, NI
    Madhusudanaraju, S
    Schmidt, JA
    Kozarich, JW
    Wong, KK
    [J]. BIOCHEMISTRY, 1996, 35 (29) : 9567 - 9575
  • [8] CLEMENT B, 1994, DRUG METAB DISPOS, V22, P486
  • [9] N-phenylamidines as selective inhibitors of human neuronal nitric oxide synthase:: Structure-activity studies and demonstration of in vivo activity
    Collins, JL
    Shearer, BG
    Oplinger, JA
    Lee, SL
    Garvey, EP
    Salter, M
    Duffy, C
    Burnette, TC
    Furfine, ES
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2858 - 2871
  • [10] COWART M, 1998, J MED CHEM, V4